Literature DB >> 33598796

Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review.

Igor Lopes Dos Santos1, Karlla Greick Batista Dias Penna2, Megmar Aparecida Dos Santos Carneiro3, Larisse Silva Dalla Libera4, Jéssica Enocencio Porto Ramos2, Vera Aparecida Saddi2.   

Abstract

Colorectal cancer (CRC) is a multifactorial disease commonly diagnosed worldwide, with high mortality rates. Several studies demonstrate important associations between differential expression of micro-RNAs (miRs) and the prognosis of CRC. The present study aimed to identify differentially expressed tissue miRs associated with prognostic factors in CRC patients, through a systematic review of the Literature. Using the PubMed database, Cochrane Library and Web of Science, studies published in English evaluating miRs differentially expressed in tumor tissue and significantly associated with the prognostic aspects of CRC were selected. All the included studies used RT-PCR (Taqman or SYBR Green) for miR expression analysis and the period of publication was from 2009 to 2018. A total of 115 articles accomplished the inclusion criteria and were included in the review. The studies investigated the expression of 100 different miRs associated with prognostic aspects in colorectal cancer patients. The most frequent oncogenic miRs investigated were miR-21, miR-181a, miR-182, miR-183, miR-210 and miR-224 and the hyperexpression of these miRs was associated with distant metastasis, lymph node metastasis and worse survival in patients with CRC. The most frequent tumor suppressor miRs were miR-126, miR-199b and miR-22 and the hypoexpression of these miRs was associated with distant metastasis, worse prognosis and a higher risk of disease relapse (worse disease-free survival). Specific tissue miRs are shown to be promising prognostic biomarkers in patients with CRC, given their strong association with the prognostic aspects of these tumors, however, new studies are necessary to establish the sensibility and specificity of the individual miRs in order to use them in clinical practice.

Entities:  

Keywords:  Colorectal neoplasms; MicroRNA; Oncology; Prognosis; Systematic review

Mesh:

Substances:

Year:  2021        PMID: 33598796     DOI: 10.1007/s11033-020-06075-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  115 in total

1.  Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients.

Authors:  Barbara Pardini; Fabio Rosa; Alessio Naccarati; Veronika Vymetalkova; Yuanqing Ye; Xifeng Wu; Cornelia di Gaetano; Tomas Buchler; Jan Novotny; Giuseppe Matullo; Pavel Vodicka
Journal:  Carcinogenesis       Date:  2014-11-03       Impact factor: 4.944

Review 2.  Towards a molecular understanding of microRNA-mediated gene silencing.

Authors:  Stefanie Jonas; Elisa Izaurralde
Journal:  Nat Rev Genet       Date:  2015-06-16       Impact factor: 53.242

Review 3.  An overview of microRNAs.

Authors:  Scott M Hammond
Journal:  Adv Drug Deliv Rev       Date:  2015-05-12       Impact factor: 15.470

Review 4.  MicroRNAs and Epigenetics.

Authors:  Catia Moutinho; Manel Esteller
Journal:  Adv Cancer Res       Date:  2017-08-04       Impact factor: 6.242

Review 5.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

Review 6.  Determinants of recurrence after intended curative resection for colorectal cancer.

Authors:  Michael Wilhelmsen; Thomas Kring; Lars N Jorgensen; Mogens Rørbæk Madsen; Per Jess; Orhan Bulut; Knud Thygesen Nielsen; Claus Lindbjerg Andersen; Hans Jørgen Nielsen
Journal:  Scand J Gastroenterol       Date:  2014-11-05       Impact factor: 2.423

7.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

8.  Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.

Authors:  Yuji Toiyama; Keun Hur; Koji Tanaka; Yasuhiro Inoue; Masato Kusunoki; C Richard Boland; Ajay Goel
Journal:  Ann Surg       Date:  2014-04       Impact factor: 12.969

9.  MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial.

Authors:  T F Hansen; R dP Christensen; R F Andersen; F B Sørensen; A Johnsson; A Jakobsen
Journal:  Br J Cancer       Date:  2013-08-06       Impact factor: 7.640

10.  Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development.

Authors:  Luca Falzone; Letizia Scola; Antonino Zanghì; Antonio Biondi; Antonio Di Cataldo; Massimo Libra; Saverio Candido
Journal:  Aging (Albany NY)       Date:  2018-05-18       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.